Bicarbonate kinetics and predicted energy expenditure in critically ill children

Jama Sy1, Anand Gourishankar, William E Gordon

  • 1Critical Care Section, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.

Insights

Accurately measuring energy expenditure in critically ill children is crucial. Bicarbonate kinetics, a novel method, provides precise energy expenditure determination, outperforming traditional predictive equations.

Area of Science:

  • Metabolic research
  • Pediatric intensive care
  • Nutritional science

Background:

  • Determining nutrient requirements in critically ill children using carbon oxidation techniques necessitates understanding non-excreted carbon dioxide.
  • This specific fraction of carbon dioxide has not been previously characterized in critically ill pediatric populations.
  • Estimating carbon dioxide appearance rates and energy expenditure requires knowledge of bicarbonate dilution kinetics and dietary energy equivalents.

Purpose of the Study:

  • To determine bicarbonate fractional recovery, rates of appearance, and energy expenditure in critically ill children.
  • To compare energy expenditure determined by bicarbonate kinetics with established predictive equations.

Main Methods:

  • A 6-hour primed, continuous infusion of sodium bicarbonate labeled with Carbon-13 (NaH(13)CO(3)) was administered to 31 critically ill children.
  • Patients were categorized based on nutritional support: parenteral nutrition, enteral nutrition, or glucose-electrolytes only.
  • Stratification included age, body mass index (BMI), and Pediatric Risk of Mortality (PRISM III) scores.

Main Results:

  • Fractional bicarbonate recovery rates were 0.69 (parenteral), 0.70 (enteral), and 0.63 (glucose-electrolytes).
  • Recovery correlated with disease severity in parenteral and glucose-electrolyte groups.
  • Energy expenditure was determined using these data and estimated energy equivalents of carbon dioxide.

Conclusions:

  • Bicarbonate dilution kinetics offers an accurate method for determining energy needs in critically ill children.
  • Traditional predictive equations (WHO 2001, Schofield) showed discrepancies, overestimating or underestimating energy requirements compared to bicarbonate kinetics.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Bicarbonate-Carbonic Acid Buffer01:22

Bicarbonate-Carbonic Acid Buffer

The carbonic acid-bicarbonate buffer system is critical for maintaining the body's pH balance. It operates on the equilibrium:
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Diagnosing Acidosis and Alkalosis01:24

Diagnosing Acidosis and Alkalosis

Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2  and HCO3−  values are examined to...